4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced

Related Keywords

United States ,Julie Seidel ,Alex Stevenson ,Duncan Peyton ,Lynne Dardanell ,Dominic Wilson ,Philip Davies James Fischer ,Chardan Metagenomics ,Neil Hunter Michelle Boxall ,Merck Co Inc ,Bryan Garnier Co ,Image Box Communications ,Nasdaq ,Chief Executive Officer ,Chief Scientific Officer ,Microbiome Medicines Summit ,Capital Markets Nominated Adviser ,Joint Broker ,Davies James Fischer ,Corporate Finance ,Corporate Broking ,Hunter Michelle Boxall ,Pharma ,Articipate ,Chardan ,Metagenomics ,Icrobiome ,Medicines ,Summit ,